Investment Team

Justin Burk

Justin Burk joined Moody’s Investor Services in 1998, moving to Carlyle High Yield Partners as an analyst in 1999. In 2001, he joined Aslan Capital Management, a high yield event-driven hedge fund, where he specialized in corporate structure analysis and asset valuation. Justin received an A.B. in Biochemical Sciences with Honors from Harvard University, and holds a Chartered Financial Analyst designation. Justin joined DSM in 2002.

Pinaki Kar

Pinaki Kar started his career in life-sciences strategy consulting at ZA Associates in 1994 where he advised pharmaceutical and biotechnology clients on strategic options, sales and marketing strategy and tactics as well as post-merger integration and restructuring of commercial operations. He subsequently worked at Pfizer and Bristol-Myers Squibb in various roles within brand planning and management. His most recent role was at Novartis AG where he was responsible for screening and assessment of strategic investment opportunities. Pinaki holds a Bachelors in Mechanical Engineering from the Indian Institute of Technology and a Masters in Logistics from the Massachusetts Institute of Technology, where he was on the Deans List. He also holds a Masters in Engineering from Notre Dame and an MBA in Finance from New York University, where he earned the Stern Scholar designation. Pinaki joined DSM in 2008.

Paul Matlow

Paul Matlow began his career at Francis I. Dupont, later moving to Argus Research and Shearson Hayden Stone. In 1974, he joined Lazard Freres Asset Management, where he remained until joining DSM. While at Lazard, Paul’s responsibilities encompassed research director, portfolio manager, supervisory analyst and sector team leader. In his equity analysis, Paul has specialized in consumer products; pharmaceuticals, biotechnology and other healthcare; and retailing. Paul holds a Bachelor of Arts degree in Economics from Brooklyn College, and also attended the Bernard Baruch Graduate School of Business. Paul holds a Chartered Financial Analyst designation and joined DSM in 2001.

David McVey

David McVey started out in 1992 at Mutual Funds Service Company in Boston. In 1995 he became an equity research associate for biotechnology and healthcare at Hambrecht & Quist. He then moved to Furman Selz, becoming a vice president and serving as a media and entertainment analyst. Most recently, he has been media and entertainment associate analyst at J.P. Morgan H&Q. David received a Bachelor of Science degree in Economics and Finance from New Hampshire College and holds a Chartered Financial Analyst designation. David joined DSM in 2001.

Takehiko Serai

Takehiko Serai began his career in 1996 at Bartlett & Company (A Legg Mason Company) as an international investment analyst. He joined Gabelli Asset Management in 2001 and worked as a long-short portfolio manager/international equity analyst. In 2007, he was recruited by Nikko Asset Management Americas to design, launch and manage a long/short fund. He joined Arteaga Capital Management in 2009 as an international equity analyst with a particular focus on Asian equities. Take joined DSM in 2011. Take earned his Master of Public and International Affairs from the University of Pittsburgh and Bachelor of Arts in International Studies from Wilkes University. He also attended Carnegie Mellon University. Take holds a Chartered Financial Analyst designation.

Steve Tish

Steve Tish began his career at Lazard Freres Asset Management in 1991 as an analyst/portfolio manager. He covered a multitude of industries including technology, healthcare, business services, and conglomerates. Steve then moved to PAW Partners in Greenwich as a partner and analyst/portfolio manager where he was responsible for the P&L of the healthcare segment of a multi-sector hedge fund. He then joined Millennium Partners in New York as a partner and analyst/portfolio manager where he worked with a team which was dedicated to their global healthcare hedge fund. The members of the team later left Millennium to start Panacea Asset Management, an independent healthcare sector hedge fund in New York. He joined DSM in October 2007. Steve earned a B.S. in Finance from the University of Maryland, an MBA from Cornell University and holds a Chartered Financial Analyst designation.

Eric Woodworth

Eric Woodworth joined Price Waterhouse Coopers in 1994 as a technology consultant. He became a team leader and managed projects for PWC in Toronto and Chicago. He also served as an internal instructor for PWC in Tampa, Florida. Eric left PWC in 1999 to attend business school, spending his summer in equity research at Merrill Lynch. Eric holds a Bachelor of Arts in Economics from Williams College, an MBA in Finance from New York University, and a Chartered Financial Analyst designation. Eric joined DSM in 2001.

Ling Zhang

Ling Zhang began her career in finance at Lehman Brothers where she worked as an investment banking associate in its global M&A group in New York from 2000 to 2002. She then moved to KBC Financial Products as a dedicated credit analyst for the convertible bond trading desk where she researched and recommended trade ideas for both clients and proprietary trading activities. Ling joined Forest Investment in 2004 where she worked as a senior analyst responsible for conducting research on Asian and European companies. From 2007-2009, she worked at Basso Capital Management focusing on generating trade ideas in Asian equities and convertible bonds. Ling joined DSM in December 2009. Ling holds a Bachelor of Arts Degree from Smith College, summa cum laude, and an MBA degree from the MIT Sloan School of Management. Prior to attending business school, she worked at Cambridge Economics as a senior analyst. Ling holds a Chartered Financial Analyst designation.